Pharma Prices, Streaming Challenges, and Market Shifts

This chapter analyzes significant pricing changes in pharmaceuticals, particularly a drastic reduction that benefits cash-paying patients. It also explores Disney's recent earnings, highlighting subscriber growth amidst competitive pressures, and contrasts the financial trajectories of Netflix and Disney. The discussion further extends to Uber's mixed performance and the evolving retail landscape amid tariff challenges, offering insights into market dynamics.